Tian Leng
Overview
Explore the profile of Tian Leng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu C, Li X, Leng T, Zhang W, Liao Q, Shu L, et al.
Sichuan Da Xue Xue Bao Yi Xue Ban
. 2023 May;
54(3):667-672.
PMID: 37248603
Objective: To compare the consistency and accuracy of a rapid test method and a traditional test method for pathogen identification, antimicrobial susceptibility and carbapenemase type identification of positive blood culture...
2.
Ma X, Ma J, Leng T, Yuan Z, Hu T, Liu Q, et al.
Ren Fail
. 2023 Feb;
45(1):2146512.
PMID: 36762989
Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is...
3.
Ma X, Zhang X, Leng T, Ma J, Yuan Z, Gu Y, et al.
Evid Based Complement Alternat Med
. 2023 Jan;
2022:1067504.
PMID: 36624863
Background: Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease throughout the world. In kidney disease, oxidative stress has been linked to both antioxidant depletions and increased...
4.
Yuan Z, Pan Y, Leng T, Chu Y, Zhang H, Ma J, et al.
J Pharm Pharm Sci
. 2022 Jun;
25:218-226.
PMID: 35760072
In recent years, the emerging network pharmacology has been extensively applied to the field of traditional Chinese medicine and has made great contributions to the modernization of TCM. Therefore, this...
5.
Zheng S, Zhuang T, Tang Y, Wu R, Xu T, Leng T, et al.
Exp Ther Med
. 2021 Sep;
22(5):1199.
PMID: 34584544
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the colon. The aim of the present study was to explore the effects of leonurine (YMJ) on inflammation and intestinal...
6.
Du Q, Zeng H, Yuan L, Tang P, Gao W, Xu J, et al.
Vaccine
. 2021 May;
39(24):3304-3309.
PMID: 33980399
Objective: To analyze the serotype distribution and drug resistance of Streptococcus pneumoniae isolated from hospitalized patients of all ages in Zhongjiang county, Sichuan province, where the young children have just...
7.
Gu Z, Duan M, Sun Y, Leng T, Xu T, Gu Y, et al.
Med Sci Monit
. 2020 Nov;
26:e925068.
PMID: 33177483
BACKGROUND Rifaximin is an antimicrobial agent used to treat inflammatory bowel disease (IBD). Vitamin D3 can control IBD due to its effects on inflammatory cytokines. The purpose of this study...
8.
Xu T, Li X, Leng T, Zhuang T, Sun Y, Tang Y, et al.
Med Sci Monit
. 2020 Apr;
26:e922149.
PMID: 32284524
BACKGROUND Leonurine is an active component of the traditional Chinese medicine Leonurus japonicus. This study aimed to investigate the effects of overexpressed CYP450s on the metabolic activity of leonurine. MATERIAL...